Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

Cancer Imaging · 2026 · PMC13330063 · PMID 42381110

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, although ADC vol was found to a predictive marker by ROC analysis (Tables 4 and 5 ), the positive odds ratio associated with regression modelling of ADC vol did not reach statistical significance (Fig. 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [&lt;sup&gt;68&lt;/sup&gt;Ga]GaPSMA-PET/CT for [&lt;sup&gt;177&lt;/sup&gt;Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).

The sentences

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [<sup>68</sup>Ga]GaPSMA-PET/CT for [<sup>177</sup>Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).